Monday, 11 February 2013

Neuropathy And HIV Connection Study

Today's post from news-medical.net (see link below) announces a new study of the link between the body's immune reaction to inflammation and what that has to do with HIV-related neuropathy. The claim that as many as 69.4% of HIV patients are affected by neuropathy, is wildly different to most to most statistics (most state that between 30 and 40% suffer from neuropathic symptoms) but that isn't the point here. To be awarded $1.9 million for a study is not peanuts and the study may prove once and for all the connection between the virus having caused cellular inflammation and the ensuing onset of neuropathy. Taken to its logical conclusion; treatments of that cellular disruption may help or prevent nerve damage in the future.


Boston College biologist to explore connection between peripheral neuropathy and HIV
Published on February 6, 2013

Boston College biologist Tricia Burdo has been awarded a five-year, $1.9 million grant from the National Institutes of Health to study the role of the body's immune response in a debilitating form of nerve damage suffered by people living with HIV.

Among HIV patients, as many as 69.4 percent are afflicted with peripheral neuropathy of the arms, legs, hands, feet, fingers and toes. The most common neurological disorder associated with people living with HIV, it is known as "dying back", a painful condition where sensory nerves die and then retreat, causing a loss of sensitivity and function.

Burdo, an associate research professor in the lab of Professor of Biology Ken Williams, said the group has been exploring the connection between peripheral neuropathy and inflammation in the dorsal root ganglia located outside of the spine. The focal point is macrophage activation, the disruptive activity of cells associated with the body's immunological response to infection.

The presence and behavior of those cells could help to determine what triggers peripheral neuropathy in HIV patients, Burdo said.

"We're studying what's going on in dorsal root ganglia in terms of inflammation by macrophage activation and correlating that to this nerve loss," said Burdo.

Central to the study, funded by the NIH's National Institute of Neurological Disorders and Stroke (NINDS), is the molecule CD163, identified by Burdo and Williams as a biological marker for the activation of macrophages and monocytes in patients with HIV.

Burdo said the team hopes to develop a clearer understanding of the progression of peripheral neuropathy, how to pinpoint early and advanced stages of neuropathy with biomarkers, and potential drug therapies that could stop or slow the disease.

Source: Boston College
http://www.news-medical.net/news/20130206/Boston-College-biologist-to-explore-connection-between-peripheral-neuropathy-and-HIV.aspx?utm_source=twitterfeed&utm_medium=twitter

No comments:

Post a Comment

All comments welcome but advertising your own service or product will unfortunately result in your comment not being published.